O22.3 Deep phlebothrombosis in pregnancy

Name of the Condition

• Deep Phlebothrombosis in Pregnancy (O22.3)

Summary

Deep phlebothrombosis in pregnancy is a condition characterized by the formation of a blood clot in a deep vein, typically in the lower extremities, during pregnancy. This condition arises due to physiological changes in pregnancy that increase the risk of venous stasis and hypercoagulability. It requires prompt recognition and management to prevent complications, such as pulmonary embolism.

Causes

The development of deep phlebothrombosis in pregnancy is primarily driven by increased venous stasis from the growing uterus compressing pelvic veins and the inferior vena cava, which impairs blood return from the lower body. Hormonal changes, such as elevated progesterone, reduce venous tone and promote clot formation. Additionally, increased blood volume and hypercoagulability during pregnancy further contribute to the risk of thrombus development.

Risk Factors

• Multiple pregnancies (e.g., twins or higher-order multiples).
• Prolonged immobility or bed rest.
• Personal or family history of venous thromboembolism.
• Obesity or excessive weight gain during pregnancy.
• Pre-existing thrombophilia or coagulation disorders.
• Advanced maternal age.

Symptoms

• Unilateral leg swelling, warmth, or redness.
• Pain or tenderness in the affected limb, often worsening with standing or walking.
• Visible enlargement of superficial veins.
• Calf pain or cramping, especially when dorsiflexing the foot (Homan’s sign, though not specific).
• Low-grade fever or systemic symptoms in severe cases.

Diagnosis

Diagnosis typically involves a combination of clinical assessment and imaging. Doppler ultrasound is the primary tool to visualize deep vein thrombosis, assessing for clot presence, location, and extent. Laboratory tests, such as D-dimer, may support diagnosis but are less specific in pregnancy. Clinical suspicion, especially with risk factors, guides further evaluation to rule out other conditions.

Treatment Options

Treatment focuses on anticoagulation to prevent clot extension and embolism. Low-molecular-weight heparin (LMWH) is commonly used due to its safety profile in pregnancy. Graduated compression stockings may reduce swelling and improve venous return. In severe cases, thrombolytic therapy or inferior vena cava filter placement may be considered. Postpartum, treatment duration depends on risk factors and clot burden.

Prognosis and Follow-Up

With appropriate treatment, the prognosis is generally good, though recurrence risk persists during pregnancy and postpartum. Follow-up includes monitoring for symptoms, repeat imaging if needed, and adjusting anticoagulation. Long-term management may involve continued prophylaxis in subsequent pregnancies or for underlying thrombophilias.

Complications

• Pulmonary embolism, a life-threatening complication if the clot dislodges.
• Post-thrombotic syndrome, characterized by chronic pain, swelling, or skin changes.
• Recurrent venous thromboembolism during or after pregnancy.
• Rarely, venous gangrene or compartment syndrome in severe cases.

Lifestyle & Prevention

• Stay active with regular, low-impact exercise (e.g., walking) to promote circulation.
• Avoid prolonged sitting or standing; take breaks to move.
• Maintain a healthy weight to reduce venous pressure.
• Stay hydrated and avoid dehydration, which can increase clotting risk.
• Use compression stockings as recommended by a healthcare provider.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden shortness of breath, chest pain, or cough (possible pulmonary embolism), or if leg swelling, pain, or redness worsens rapidly. Prompt evaluation is critical to prevent complications.

Tips for Medical Coders

Document the presence of deep phlebothrombosis, including location (e.g., lower extremity) and any associated symptoms or complications. Ensure clinical correlation with diagnostic imaging (e.g., ultrasound) and note any anticoagulation therapy. For coding, confirm the condition is pregnancy-related and not pre-existing, as O22.3 is specific to pregnancy.